The drug-device combination products industry is rapidly evolving, with a focus on integrating advanced technologies to enhance drug delivery and patient outcomes. Wearable injectors, such as YpsoMate by Ypsomed, are being developed for chronic conditions, enabling patients to administer biologics...Read More »
August 20, 2024
The U.S. burn care centers market size was estimated at USD 7.95 billion in 2023 and is expected to grow at a CAGR of 3.74% from 2024 to 2030. Burn care centers in the U.S. are specialized facilities that manage a range of burn injuries, from minor burns to life-threatening thermal injuries.
...Read More »August 20, 2024
The stem cell industry has experienced rapid growth over the past decade, driven by advancements in biotechnology, increasing demand for regenerative medicine, and a growing interest in personalized medicine. Stem cells, with their unique ability to differentiate into various cell types, have beco...Read More »
August 19, 2024
The growing number of clinical trials across the globe in past few years has significantly increased the overall clinical trial costs. High clinical cost of clinical trial is owing to complexity of novel therapies such as personalized medicine and cell & gene therapy, and stringent regulatory ...Read More »
August 16, 2024
The study covers drug and alcohol abuse treatment facilities at state, county, and city level which helps to understand details regarding their location, address, ownership, services offered, and other parameters.
...Read More »August 13, 2024
In June 2024, phase III SURMOUNT-OSA trial data from Eli Lilly highlights the potential of GLP-1s in managing OSA. The trial compared the efficacy of GLP-1s alone and in combination with positive airway pressure (PAP) over 12 months. The combination therapy showed a 62.8% reduction in apnea-hypopn...Read More »
August 13, 2024
The U.S. integrated delivery network market size was estimated at USD 1.92 trillion in 2023 and is expected to expand at a CAGR of 10.25% from 2024 to 2030. The study covers integrated delivery networks in the U.S. which helps to understand details regarding their corporate executive names, design...Read More »
August 13, 2024
Cell therapies have emerged as a leading sector in the biopharmaceutical industry, marked by significant advancements toward potentially curative treatments for complex diseases using innovative scientific approaches. This field has recently seen a surge in billion-dollar investments and numerous ...Read More »
August 13, 2024
The COVID-19 pandemic brought mRNA vaccines to the forefront, highlighting their rapid development and high efficacy in addressing urgent health needs. While the focus has largely been on COVID-19 vaccines, a significant amount of research is being conducted on mRNA vaccines for cancer treatment.<...Read More »
August 13, 2024
Our healthcare portfolio has been developing since our inception in 2014, wherein we have tracked numerous sub-domains and their R&D activities. We have actively been tracking the CDMOs space and have seen the evolution of these players from just a handful to now over 100 companies.
...Read More »August 13, 2024
Our healthcare portfolio has been developing since our inception in 2014, wherein we have tracked numerous sub-domains and their R&D activities. We have actively been tracking the CDMOs space and have seen the evolution of these players from just a handful to now over 100 companies.
...Read More »August 12, 2024
Diabetic foot ulcer is a severe complication of diabetes mellitus, associated with high morbidity, mortality, and reduced quality of life. The incidence of diabetic foot ulcer (DFU) continues to rise. Among the estimated 537 million people globally living with diabetes, between 19% and 34% are exp...Read More »
August 12, 2024
Our healthcare outsourcing portfolio has been developing since our inception in 2014, wherein we have been continuously tracking several sub-domains such as clinical trials, CRO, CDMO, CMO, and specialty service providers space and their R&D activities, financial performance, strategic initiat...Read More »
August 12, 2024
Our healthcare portfolio has been developing since our inception in 2014, wherein we have tracked numerous sub-domains and their R&D activities. We have actively been tracking the sequencing technology space and have seen the evolution of these players over time. To help understand and highlig...Read More »
August 12, 2024
Key factors driving the research, development, and launch of gene therapy products include increasing regulatory support, patient demand, technological advancements in gene editing techniques, and market potential for innovative treatments for chronic diseases. Gene therapies hold significant prom...Read More »
August 12, 2024
The malaria diagnostics market is evolving rapidly with a growing emphasis on point-of-care testing (POCT) for quick and accurate results, crucial for remote areas. Innovations such as the microfluidic point-of-care immunoassay highlight significant advancements, delivering results in just 15 minu...Read More »
August 12, 2024
Technological advancements in drug delivery devices are driven by the need for better patient compliance, improved therapeutic outcomes, and personalized treatments. The growing prevalence of diabetes and cardiovascular diseases (CVD), coupled with the rise in biologic drug development, has spurre...Read More »
August 12, 2024
The global in vitro diagnostics quality control market size was estimated at USD 1.28 billion in 2023 and is projected to grow at a CAGR of 3.2% from 2024 to 2030. An increasing number of accredited clinical laboratories worldwide and the presence of favorable regulatory policies are expected to d...Read More »
August 8, 2024
The competitive analysis of the ophthalmic devices industry in the U.S. is driven by several key factors. The aging population significantly impacts market growth as conditions like cataracts, glaucoma, and age-related macular degeneration become more prevalent, increasing the demand for diagnosti...Read More »
August 8, 2024
The global healthcare assistive robots market size was estimated at USD 27.3 billion in 2023 and is projected to grow at a CAGR of 16.6% from 2024 to 2030. The market encompasses a range of segments such as surgical, exoskeleton, pharmaceutical, cleanroom, prosthetics, medical service, and companion robots.
...Read More »August 8, 2024
Tell us what you need. We reply within one working day.
This report has a service guarantee. We stand by our report quality.
Your transaction & personal information is safe and secure.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.